Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
20.07
-0.08 (-0.40%)
At close: Mar 6, 2026, 4:00 PM EST
20.38
+0.31 (1.54%)
After-hours: Mar 6, 2026, 6:14 PM EST
Apellis Pharmaceuticals Employees
As of December 31, 2025, Apellis Pharmaceuticals had 739 total employees, including 733 full-time and 6 part-time employees. The number of employees increased by 29 or 4.08% compared to the previous year.
Employees
739
Change (1Y)
29
Growth (1Y)
4.08%
Revenue / Employee
$1,358,298
Profits / Employee
$30,295
Market Cap
2.57B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Adaptive Biotechnologies | 619 |
| Arcus Biosciences | 601 |
| Beam Therapeutics | 511 |
| Travere Therapeutics | 497 |
| Wave Life Sciences | 317 |
| Dyne Therapeutics | 240 |
| Vera Therapeutics | 224 |
APLS News
- 5 days ago - Apellis Pharmaceuticals, Inc. (APLS) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 5 days ago - Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors - GlobeNewsWire
- 11 days ago - Apellis Pharmaceuticals, Inc. (APLS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 12 days ago - Apellis Pharmaceuticals to Present at the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 16 days ago - Apellis Announces Eight Oral Presentations at the 49th Macula Society Annual Meeting - GlobeNewsWire
- 25 days ago - Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600 - PRNewsWire